Stockholder Equity (Details Narrative) - USD ($)
|
|
|
1 Months Ended |
12 Months Ended |
|
Jun. 06, 2025 |
Jan. 15, 2025 |
Dec. 23, 2025 |
Aug. 28, 2025 |
Jul. 18, 2025 |
Apr. 30, 2025 |
Nov. 18, 2024 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Oct. 30, 2020 |
| Common stock, shares authorized |
|
|
|
|
|
|
|
1,000,000,000
|
1,000,000,000
|
|
| Granted |
|
|
|
|
|
|
|
1,193,076
|
|
|
| Common stock, par value |
|
|
|
|
|
|
|
$ 0.0001
|
$ 0.0001
|
|
| Preferred stock, shares authorized |
|
|
|
|
|
|
|
50,000,000
|
500,000,000
|
|
| Preferred stock, par value |
|
|
|
|
|
|
|
$ 0.0001
|
$ 0.0001
|
|
| Preferred stock, shares designated |
|
|
|
|
|
|
|
1,000,000
|
1,000,000
|
|
| Fair value of common share |
|
|
|
|
|
|
|
$ 290,872
|
$ 383,879
|
|
| Cash proceeds |
|
|
|
|
|
|
|
$ 24,000
|
60,000
|
|
| Vested |
|
|
|
|
|
|
|
198,154
|
|
|
| Stock-based compensation |
|
|
|
|
|
|
|
$ 3,546,646
|
$ 1,215,624
|
|
| Common stock, shares issued |
|
|
|
|
|
|
|
17,143,771
|
14,130,198
|
|
| Common stock, shares outstanding |
|
|
|
|
|
|
|
17,143,771
|
14,130,198
|
|
| Warrants outstanding |
|
|
|
|
|
|
|
865,296
|
354,929
|
|
| Repurchase of Warrants |
|
|
|
|
|
|
|
$ 649,980
|
$ 0
|
|
| Preferred stock, shares outstanding |
|
|
|
|
|
|
|
0
|
0
|
|
| Preferred stock, shares issued |
|
|
|
|
|
|
|
0
|
0
|
|
| Incremental value from exercise price reduction as deemed dividend |
|
|
|
|
|
|
|
$ 573,928
|
|
|
| Proceeds from the exercise of options |
|
|
|
|
|
|
|
9,312,840
|
$ 12,291,775
|
|
| Stock issuance costs |
|
|
|
|
|
|
|
$ 404,200
|
$ 902,256
|
|
| Stock Option [Member] |
|
|
|
|
|
|
|
|
|
|
| Number of option include performance conditions |
|
|
|
|
|
|
|
146,809
|
|
|
| Vest period |
|
|
|
|
|
|
|
4 years
|
|
|
| Weighted-average period |
|
|
|
|
|
|
|
1 year 6 months 3 days
|
|
|
| Weighted Average exercise price, granted |
|
|
|
|
|
|
|
$ 4.38
|
$ 4.60
|
|
| Unrecognized compensation expense |
|
|
|
|
|
|
|
$ 2,637,204
|
|
|
| Unvested RSUs outstanding |
|
|
|
|
|
|
|
327,500
|
617,500
|
|
| Options exercisable |
|
|
|
|
|
|
|
312,500
|
|
|
| Stock-based compensation |
|
|
|
|
|
|
|
$ 1,834,648
|
$ 907,225
|
|
| Vest Upon Achievement Of 50% Target [Member] | Stock Option [Member] |
|
|
|
|
|
|
|
|
|
|
| Vested percentage |
|
|
|
|
|
|
|
50.00%
|
|
|
| Vest Upon Achievement Of 50% Revenue Target [Member] | Stock Option [Member] |
|
|
|
|
|
|
|
|
|
|
| Vested percentage |
|
|
|
|
|
|
|
20.00%
|
|
|
| Revenue Target |
|
|
|
|
|
|
|
$ 100,000,000
|
|
|
| Achive revenue target |
|
|
|
|
|
|
|
15,000,000
|
|
|
| Annual revenue achive for fiscal year 2026 |
|
|
|
|
|
|
|
$ 20
|
|
|
| Stock Option [Member] | Vest Upon Achievement Of 20% Revenue Target [Member] |
|
|
|
|
|
|
|
|
|
|
| Vested percentage |
|
|
|
|
|
|
|
50.00%
|
|
|
| Revenue Target |
|
|
|
|
|
|
|
$ 100,000,000
|
|
|
| Board of Directors and Executive [Member] |
|
|
|
|
|
|
|
|
|
|
| Dividend Yield |
|
|
|
|
|
|
|
0.00%
|
|
|
| Expected Life |
|
|
|
|
|
|
|
5 years
|
|
|
| Common stock, shares issued |
|
|
|
|
|
|
55,680
|
|
|
|
| Expected Volatility |
|
|
|
|
|
|
|
24.80%
|
|
|
| Risk-free Interest Rate |
|
|
|
|
|
|
|
4.28%
|
|
|
| Proceeds from the exercise of options |
|
|
|
|
|
|
$ 696,000
|
|
|
|
| Warrants issued |
|
|
|
|
|
|
83,520
|
|
|
|
| 2021 Plan [Member] |
|
|
|
|
|
|
|
|
|
|
| Issuance of common shares |
|
|
|
|
|
|
|
2,400,000
|
|
|
| 2025 Sales Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
| Price per share |
|
|
|
|
|
|
|
$ 3.50
|
|
|
| Non-affiliate shares |
|
|
|
|
|
|
|
$ 11,184,116
|
|
|
| Public float amount |
|
|
|
|
|
|
|
$ 39,144,000
|
|
|
| Equity securities issued under at-the-market offering program |
$ 15,100,000
|
|
$ 50,000,000
|
|
|
|
|
|
|
|
| Description of remaining availability under sales agreement |
|
|
|
|
|
|
|
the aggregate market value of shares of our common stock held by non-affiliates in any 12-month period, so long as the aggregate market value of shares of our common stock held by non-affiliates is less than $75 million. After giving effect to the approximate $13,000,000 offering limit imposed by General Instruction I.B.6 of Form S-3 and deducting the shares sold within the preceding 12 months, as of the date of filing this Annual Report, approximately $3,700,000 shares of common stock
|
|
|
| Sale of common stock |
|
|
|
|
|
|
|
2,279,180
|
|
|
| Proceeds from the exercise of options |
|
|
|
|
|
|
|
$ 9,313,000
|
|
|
| Net proceeds from issuance |
|
|
|
|
|
|
|
8,909,000
|
|
|
| Stock issuance costs |
|
|
|
|
|
|
|
404,000
|
|
|
| 2022 Sales Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
| Sale of common stock |
|
|
|
|
|
|
|
|
5,051
|
|
| Proceeds from the exercise of options |
|
|
|
|
|
|
|
|
$ 63,100
|
|
| Net proceeds from issuance |
|
|
|
|
|
|
|
|
3,100
|
|
| Stock issuance costs |
|
|
|
|
|
|
|
|
$ 65,500
|
|
| Securities Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
| Proceeds from the exercise of options |
|
|
|
|
|
|
|
$ 8,118,000
|
|
|
| Common stock share issued |
|
|
|
|
|
|
|
978,350
|
|
|
| Warrants to purchase aggregate shares of common stock |
|
|
|
|
|
|
|
1,467,524
|
|
|
| Share issued and sell description |
|
|
|
|
|
|
|
The purchase price for one share and the accompanying 1.5 warrants was $11.25. The warrants are immediately exercisable for a period of five years from the date of the Offering at $11.25, subject to adjustment in the event of any stock dividends and splits, reverse stock split, recapitalization, reorganization, or similar transactions (“Share Combination Event”) and include anti-dilution protection provisions in the event subsequent sales or equity-linked financial instruments are issued at a price below the $11.25
|
|
|
| Gross proceeds |
|
|
|
|
|
|
$ 12,229,000
|
|
|
|
| Net proceeds |
|
|
|
|
|
|
11,393,000
|
|
|
|
| Payments for Other Fees |
|
|
|
|
|
|
$ 836,000
|
|
|
|
| Fair values of warrant |
|
|
|
|
|
|
|
$ 3,275,000
|
|
|
| Bottom [Member] | Restricted Stock Units [Member] |
|
|
|
|
|
|
|
|
|
|
| Grant-date fair value of the restricted stock |
|
|
|
|
|
|
|
$ 3.70
|
$ 10.30
|
|
| Vested |
|
|
|
|
|
|
|
143,750
|
|
|
| Top [Member] | Restricted Stock Units [Member] |
|
|
|
|
|
|
|
|
|
|
| Grant-date fair value of the restricted stock |
|
|
|
|
|
|
|
$ 6.30
|
$ 13.00
|
|
| Vested |
|
|
|
|
|
|
|
546,250
|
|
|
| Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
| Granted |
|
|
|
|
|
|
|
10,000
|
|
|
| Weighted Average exercise price, granted |
|
|
|
|
|
|
|
$ 12.50
|
|
|
| Unvested RSUs outstanding |
|
|
|
|
|
|
|
877,524
|
1,467,524
|
|
| Options exercisable |
|
|
|
|
|
|
|
877,524
|
|
|
| Dividend Yield |
|
|
|
|
|
|
|
0.00%
|
|
|
| Expected Life |
|
|
|
|
|
|
|
3 years 10 months 24 days
|
|
|
| Warrants outstanding |
|
|
|
|
|
|
|
877,524
|
|
|
| Exercise price |
|
|
|
|
|
|
|
$ 11.25
|
|
|
| Warrants granted |
|
|
|
|
|
|
|
10,000
|
|
|
| Expected Volatility |
|
|
|
|
|
|
|
107.10%
|
|
|
| Warrants Repurchased |
|
|
|
|
600,000
|
|
|
600,000
|
|
|
| Warrant Exercise price |
|
|
|
|
$ 1.08
|
|
|
$ 11.25
|
|
|
| Repurchase of Warrants |
|
|
|
|
$ 649,980
|
|
|
|
|
|
| Risk-free Interest Rate |
|
|
|
|
|
|
|
3.62%
|
|
|
| Restricted Stock [Member] |
|
|
|
|
|
|
|
|
|
|
| Common stock issued for services |
|
|
|
|
|
|
|
82,985
|
30,121
|
|
| Fair value of common share |
|
|
|
|
|
|
|
$ 290,872
|
$ 383,879
|
|
| Common stock for stock option exercises |
|
|
|
|
|
|
|
131,176
|
149,965
|
|
| Cash proceeds |
|
|
|
|
|
|
|
$ 24,000
|
$ 60,000
|
|
| Issued shares of common stock |
|
|
|
|
|
|
|
22,105
|
|
|
| Noncash transaction amount |
|
|
|
|
|
|
|
$ 105,000
|
|
|
| Fair value of share-based payment award |
|
|
|
|
|
|
|
$ 105,000
|
|
|
| Restricted Stock Units RSU [Member] |
|
|
|
|
|
|
|
|
|
|
| Granted |
|
|
|
|
|
|
|
1,193,076
|
|
|
| Number of RSUs include performance conditions |
|
|
|
|
|
|
|
125,000
|
|
|
| Unrecognized compensation expense |
|
|
|
|
|
|
|
$ 1,419,744
|
|
|
| Target number of RSUs |
|
|
|
287,500
|
|
|
|
|
|
|
| Unvested restricted stock units |
|
106,622
|
|
|
|
|
|
|
|
|
| Performance based restricted stock units |
|
|
|
|
|
106,622
|
|
|
|
|
| Unvested RSUs outstanding |
|
|
|
|
|
|
|
146,809
|
|
|
| Performance-based RSUs forfeited |
|
|
|
|
|
|
|
149,778
|
|
|
| Time-based RSUs forfeited |
|
|
|
|
|
|
|
$ 64,583
|
|
|
| Performance-based vesting conditions for restricted stock units |
|
|
|
|
|
|
|
The performance-based units vest as follows: 50% vest upon the achievement of Operating Profit, as defined in the employment agreements, and 50% upon the achievement of revenue targets between $15 and $100 million by the end of fiscal year 2028. The restricted stock units with the revenue target begin vesting once the Company achieves $15.0 million in revenue for a fiscal year. Vesting will occur on January 31 of each year through January 31, 2029. The number of restricted stock units that vest is based on the proportionate percentage of each fiscal year’s revenue to the $100 million target. For example, if our annual revenue for fiscal year 2026 is $20 million, 20% of the restricted stock units with the revenue performance condition will vest on January 31, 2027
|
|
|
| Vesting conditions for restricted stock units |
|
|
|
our board of directors was granted 228,332 RSUs that will fully vest on the one-year grant-date anniversary. Effective, December 15, 2025, one of our board of directors resigned from the Company and 61,697 RSUs granted to the director on August 28, 2025 became fully vested
|
|
|
|
|
|
|
| Stock-based compensation |
|
|
|
|
|
|
|
$ 438,160
|
|
|
| Restricted Stock Units RSU [Member] | key employee [Member] |
|
|
|
|
|
|
|
|
|
|
| Granted |
|
176,500
|
|
|
|
|
|
|
|
|
| Forfeited |
|
|
|
|
|
|
|
7,000
|
|
|
| Unvested RSUs outstanding |
|
|
|
|
|
|
|
169,500
|
|
|
| Restricted Stock Units RSU [Member] | Bottom [Member] |
|
|
|
|
|
|
|
|
|
|
| Vest period |
|
|
|
|
|
|
|
1 year
|
|
|
| Restricted Stock Units RSU [Member] | Top [Member] |
|
|
|
|
|
|
|
|
|
|
| Vest period |
|
|
|
|
|
|
|
4 years
|
|
|
| Performance based RSUs [Member] |
|
|
|
|
|
|
|
|
|
|
| Granted |
|
|
|
287,500
|
|
|
|
|
|
|
| Forfeited |
|
|
|
|
|
|
|
162,500
|
|
|
| Time based RSUs [Member] |
|
|
|
|
|
|
|
|
|
|
| Granted |
|
|
|
287,500
|
|
|
|
|
|
|
| Forfeited |
|
|
|
|
|
|
|
100,694
|
|
|
| Weighted-average period |
|
|
|
|
|
|
|
2 years 3 months 29 days
|
|
|
| Unrecognized compensation expense |
|
|
|
|
|
|
|
$ 2,227,374
|
|
|
| Stock-based compensation |
|
|
|
|
|
|
|
$ 1,711,998
|
$ 308,399
|
|
| Vested, outstanding number |
|
|
|
|
|
|
|
694,444
|
|
|
| Performance Based Option [Member] | Stock Option [Member] |
|
|
|
|
|
|
|
|
|
|
| Forfeited |
|
|
|
|
|
|
|
299,778
|
|
|
| Unrecognized compensation expense |
|
|
|
|
|
|
|
$ 585,303
|
|
|
| Common Stocks Shares [Member] |
|
|
|
|
|
|
|
|
|
|
| Common stock, shares authorized |
|
|
|
|
|
|
|
1,000,000,000
|
|
|
| Common stock, par value |
|
|
|
|
|
|
|
$ 0.0001
|
|
|
| Series D Convertible Preferred Stock |
|
|
|
|
|
|
|
|
|
|
| Preferred stock, par value |
|
|
|
|
|
|
|
|
|
$ 0.0001
|
| Preferred stock, shares designated |
|
|
|
|
|
|
|
|
|
1,000,000
|